MTAP (CN=1) CDKN2A (CN=1) CDKN2B (CN=1) co-loss Reference Standard
CBP40150
詢 價
索取COA
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| Introduction | ||||
| Format | Genomic DNA | |||
| Description |
MTAP loss has been commonly observed in multiple malignancies, including gliomas, pancreatic cancer, mesothelioma and non-small cell lung cancer (NSCLC). CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) is a Protein Coding gene. Diseases associated with CDKN2A include Melanoma, Cutaneous Malignant 2 and Melanoma-Pancreatic Cancer Syndrome. CDKN2B (Cyclin Dependent Kinase Inhibitor 2B) is a Protein Coding gene. Diseases associated with CDKN2B include Lipoprotein Quantitative Trait Locus and Ovarian Cancer. |
|||
| Technical Data | ||||
| Definition | Loss | |||
| Copy Number | 1.00 | |||
| DdPCR |
0.91(CDKN2A) 0.92(CDKN2B) 1.00(MTAP) |
|||
| Product Information | ||||
| Intended Use | Research Use Only | |||
| Unit Size | 1ug | |||
| Concentration | Download for COA | |||
| Purity | Download for COA | |||
| DNA electrophoresis | Download for COA | |||
| Sanger sequencing | Download for COA | |||
| Storage | 2-8℃ | |||
| Expiry | 36 months from the date of manufacture | |||
